Literature DB >> 25295129

Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.

Massimo Valerio1, Yannick Cerantola1, Urs Fritschi1, Martin Hubner2, Katia Iglesias3, Anne-Sophie Legris1, Ilaria Lucca1, Yannis Vlamopoulos1, Laurent Vaucher1, Patrice Jichlinski1.   

Abstract

INTRODUCTION: Preoperative scores are widely used predictors of complications after major surgery. These scores, however, are not widely used in transurethral procedures. The aim of this study was to assess the value of the Charlson Comorbidity Index (CCI), the age-adjusted CCI, the American Society of Anesthesiologist score (ASA) and the Nutritional Risk Score (NRS) in predicting early morbidity after transurethral urological procedures.
METHODS: Consecutive patients undergoing transurethral resection of the bladder or the prostate were prospectively enrolled. The scores were calculated preoperatively; 30-day complications were prospectively recorded according to the Dindo-Clavien classification. Univariate logistic regression was performed to investigate the value of each score and of other factors (i.e., age, sex, body mass index, anemia, smoking habit, type of operation and anaesthesia) as predictors of complications. A multivariate model was then calculated using these predictors.
RESULTS: Overall, 197 patients were included. The mean age was 72 (standard deviation ± 10). In total, 26.9% patients had at least 1 complication. Using univariate analysis, we found that each score significantly predicted complications. In multivariate analysis, only the ASA (odds ration [OR] 2.11; 95% confidence interval [CI] 1.01-4.43) and the NRS (OR 2.42; 95% CI 1.56-3.74) remained independent predictors. The best model incorporated ASA, NRS and gender, and predicted morbidity with an area under the curve of 76%. Our study's main limitations are population heterogeneity and limited sample size.
CONCLUSION: The ASA and the NRS are important and independent determinants of early morbidity after transurethral procedures. The use of these indices may assist clinicians in the decision-making process to balance the possible benefits of transurethral procedures with the potential risks.

Entities:  

Year:  2014        PMID: 25295129      PMCID: PMC4164546          DOI: 10.5489/cuaj.1848

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  18 in total

Review 1.  Anaesthesia, surgery, and challenges in postoperative recovery.

Authors:  Henrik Kehlet; Jørgen B Dahl
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

2.  Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Roman Mayr; Mattias May; Thomas Martini; Michele Lodde; Evi Comploj; Armin Pycha; Jenny Strobel; Stefan Denzinger; Wolfgang Otto; Wolfgang Wieland; Maximilian Burger; Hans-Martin Fritsche
Journal:  Eur Urol       Date:  2012-04-12       Impact factor: 20.096

3.  Preoperative comorbidities and relationship of comorbidities with postoperative complications in patients undergoing transurethral prostate resection.

Authors:  Jeong-Yeon Hong; Seung Chul Yang; Seohui Ahn; Hae Keum Kil
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

4.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

5.  ASA classification and perioperative variables as predictors of postoperative outcome.

Authors:  U Wolters; T Wolf; H Stützer; T Schröder
Journal:  Br J Anaesth       Date:  1996-08       Impact factor: 9.166

6.  Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Authors:  Jennifer M Taylor; Andrew Feifer; Caroline J Savage; Alexandra C Maschino; Melanie Bernstein; Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2011-07-01       Impact factor: 5.588

Review 7.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

8.  Prospective assessment of malnutrition in urologic patients.

Authors:  Alexander Karl; Peter Rittler; Alexander Buchner; Vincent Fradet; Robert Speer; Sebastian Walther; G Christian Stief
Journal:  Urology       Date:  2009-02-20       Impact factor: 2.649

9.  Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  Claudio Jeldres; Hendrik Isbarn; Umberto Capitanio; Laurent Zini; Naeem Bhojani; Shahrokh F Shariat; Vincent Cloutier; Jean-Baptiste Lattouf; Alain Duclos; Martine Jolivet-Tremblay; Luc Valiquette; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  J Urol       Date:  2009-06-17       Impact factor: 7.450

10.  The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery.

Authors:  Marc Schiesser; Philipp Kirchhoff; Markus K Müller; Markus Schäfer; Pierre-Alain Clavien
Journal:  Surgery       Date:  2009-03-27       Impact factor: 3.982

View more
  2 in total

Review 1.  Female with bladder cancer: what and why is there a difference?

Authors:  Phillip Marks; Armin Soave; Shahrokh F Shariat; Harun Fajkovic; Margit Fisch; Michael Rink
Journal:  Transl Androl Urol       Date:  2016-10

2.  Changing profiles of patients undergoing transurethral resection of the prostate over a decade: A single-center experience.

Authors:  Manav Agrawal; Manoj Kumar; Siddharth Pandey; Ajay Aggarwal; Satyanarayan Sankhwar
Journal:  Urol Ann       Date:  2019 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.